TRVI News and Press, Trevi Therapeutics Inc. From 11/14/25

2025-11-14 08:15:11 ET Oppenheimer analyst issues OUTPERFORM recommendation for TRVI on November 14, 2025 11:51AM ET. The previous analyst recommendation was Outperform. TRVI was trading at $11.46 at issue of the analyst recommendation. The overall analyst consensus : BU...

2025-11-13 21:22:09 ET More on Trevi Therapeutics Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript Trevi Therapeutics, Inc. (TRVI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Trevi spikes as B. Riley reportedly cit...

2025-11-13 21:21:36 ET Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript

2025-11-13 16:13:46 ET More on Trevi Therapeutics Trevi Therapeutics, Inc. (TRVI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Trevi spikes as B. Riley reportedly cites deal prospects Seeking Alpha’s Quant Rating on Trevi Th...

Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates PR Newswire Company preparing to initiate comprehensive Phase 3 program for chronic cough in patients with idiopathic pulmonary fibrosis in first half of 2026 Company ended the third q...

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025 PR Newswire Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn. , Nov. 6, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: T...

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference PR Newswire Fireside Chat with Management on Tuesday, November 11, 2025 , at 3:20 p.m. ET NEW HAVEN, Conn. , Nov. 4, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage ...

Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting PR Newswire Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of ch...